Latest News for: certolizumab pegol
Edit
Axial Spondyloarthritis Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | UCB ...
GetNews 25 Mar 2025
SIMPONI (golimumab), XELJANZ (tofacitinib), Bimekizumab, CC-99677, ABY- 035, Filgotinib, KHK4827, Ixekizumab, Golimumab, etanercept, Secukinumab, SHR0302, Certolizumab Pegol, and others ... Certolizumab Pegol.
Edit
Chronic Plaque Psoriasis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports ...
GetNews 13 Mar 2025
ZL-1102, Certolizumab pegol, CMAB015, Tildrakizumab, Guselkumab, LZM012, RWJ-445380, M923, LAS41008, Bimekizumab, Topical roflumilast, PF-06700841, ARQ-151 0.3% cream, CHS-1420, Humira (Adalimumab), ...
- 1